HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Kanbayashi Selected Research

Disorders of Excessive Somnolence (Hypersomnia)

10/2020Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.
12/2018A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.
1/2018Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
1/2018Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness.
7/2016Hypocretin-1 levels in the cerebrospinal fluid of patients with Percheron artery infarction with or without midbrain involvement: A case series.
5/2016Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome.
6/2015Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
2/2015New susceptibility variants to narcolepsy identified in HLA class II region.
1/2014[Case of herpes simplex encephalitis with hypersomnia and low orexin level in the cerebrospinal fluid].
1/2014[A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Kanbayashi Research Topics

Disease

37Narcolepsy
04/2022 - 03/2002
37Disorders of Excessive Somnolence (Hypersomnia)
10/2020 - 07/2002
20Cataplexy
01/2021 - 03/2002
8Sleepiness
02/2020 - 08/2011
7Idiopathic Hypersomnia
04/2022 - 03/2002
6Encephalitis (Encephalitis, Rasmussen)
05/2021 - 07/2007
5Neuromyelitis Optica (Devic's Disease)
08/2019 - 04/2011
4Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 06/2002
4Schizophrenia (Dementia Praecox)
01/2018 - 05/2012
4Nervous System Diseases (Neurological Disorders)
01/2018 - 08/2005
3Anti-N-Methyl-D-Aspartate Receptor Encephalitis
02/2022 - 01/2019
3Dementia (Dementias)
01/2021 - 12/2006
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 06/2002
3Infarction (Infarctions)
08/2019 - 08/2005
3Catatonia
01/2019 - 01/2014
3Treatment-Resistant Schizophrenia
08/2018 - 02/2016
3Epilepsy (Aura)
01/2018 - 03/2002
3Sleep Paralysis
01/2018 - 03/2002
3Obesity
05/2016 - 03/2011
3Demyelinating Diseases (Demyelinating Disease)
12/2009 - 08/2005
3Parkinson Disease (Parkinson's Disease)
05/2009 - 12/2006
3Brain Diseases (Brain Disorder)
02/2009 - 08/2005
3Multiple Sclerosis
07/2004 - 06/2002
2Kleine-Levin Syndrome (Syndrome, Kleine-Levin)
01/2022 - 01/2018
2Psychotic Disorders (Schizoaffective Disorder)
05/2021 - 01/2014
2Sleep Wake Disorders
10/2020 - 02/2015
2Psychomotor Agitation (Akathisia)
08/2018 - 01/2018
2Myotonic Dystrophy (Dystrophia Myotonica)
01/2018 - 07/2009
2Coma (Comas)
07/2016 - 01/2014
2Sleep Deprivation
11/2014 - 12/2003
2Inappropriate ADH Syndrome (SIADH)
01/2014 - 08/2011
2Guillain-Barre Syndrome
12/2012 - 06/2002
2Craniocerebral Trauma (Head Injury)
02/2009 - 08/2005
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
12/2006 - 12/2003
2Hypothalamic Neoplasms
09/2006 - 12/2004
2Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
11/2004 - 07/2002
1Inflammation (Inflammations)
10/2022
1Autoimmune Diseases of the Nervous System
05/2021
1Dissociative Disorders (Fugue)
05/2021
1Muscle Weakness
10/2020
1Autoimmune Diseases (Autoimmune Disease)
10/2020
1Carcinosarcoma
10/2020
1Leukocytosis (Pleocytosis)
08/2019
1Oculomotor Nerve Diseases (Oculomotor Nerve Palsy)
08/2019
1Lymphoma (Lymphomas)
06/2019
1Mood Disorders (Mood Disorder)
01/2019
1Disease Progression
01/2019
1Apnea
01/2018
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018
1Delirium
01/2018
1Hallucinations (Hallucination)
01/2018
1Pancytopenia
01/2018
1Sleep Apnea Syndromes (Sleep Apnea)
01/2018
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
01/2018

Drug/Important Bio-Agent (IBA)

54OrexinsIBA
04/2022 - 03/2002
6N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2021 - 05/2012
6AntibodiesIBA
06/2019 - 04/2011
6HLA Antigens (Human Leukocyte Antigens)IBA
12/2018 - 11/2003
5Clozapine (Clozaril)FDA LinkGeneric
08/2018 - 11/2013
5Pharmaceutical PreparationsIBA
12/2014 - 06/2002
4HLA-DQB1 antigen (HLA DQB1)IBA
10/2020 - 01/2015
4anti-aquaporin 4 autoantibodyIBA
10/2012 - 02/2009
4SteroidsIBA
10/2012 - 02/2009
3Immunoglobulin G (IgG)IBA
08/2019 - 04/2011
3LigandsIBA
05/2010 - 08/2005
2Aripiprazole (Abilify)FDA Link
10/2021 - 01/2018
2AntigensIBA
10/2020 - 06/2002
2Methylphenidate (Ritalin)FDA LinkGeneric
02/2020 - 06/2009
2Proteins (Proteins, Gene)FDA Link
08/2019 - 01/2018
21- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA
08/2018 - 01/2018
2Antipsychotic Agents (Antipsychotics)IBA
01/2018 - 01/2018
2N 30IBA
01/2018 - 08/2005
2Anticonvulsants (Antiepileptic Drugs)IBA
06/2015 - 01/2014
2Vasopressins (Vasopressin)IBA
01/2014 - 08/2011
2MethylprednisoloneFDA LinkGeneric
01/2014 - 08/2003
2Aquaporin 4IBA
01/2012 - 04/2011
2Histamine (Histamine Dihydrochloride)FDA Link
06/2009 - 02/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2005 - 07/2002
1Sevoflurane (Ultane)FDA LinkGeneric
10/2022
1LipopolysaccharidesIBA
10/2022
1LithiumIBA
01/2022
1Hypnotics and Sedatives (Sedatives)IBA
01/2022
1Rituximab (Mabthera)FDA Link
05/2021
1suvorexantIBA
01/2021
1Orexin Receptor AntagonistsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
10/2020
1pembrolizumabIBA
10/2020
1Clopidogrel (Plavix)FDA Link
08/2019
1EdaravoneIBA
08/2019
1argatroban (MPQA)FDA Link
08/2019
1BenzodiazepinesIBA
08/2018
1Biperiden (Akineton)FDA Link
08/2018
1perampanelIBA
01/2018
1Gabapentin (Neurontin)FDA LinkGeneric
01/2018
1ProdrugsIBA
01/2018

Therapy/Procedure

8Therapeutics
10/2020 - 08/2005
4Immunotherapy
02/2022 - 02/2016
4Aftercare (After-Treatment)
01/2020 - 12/2012
1Nursing Care
01/2020
1Drug Therapy (Chemotherapy)
06/2019